...
机译:联合青少年 - 成人早期临床试验,改善患有癌症的青少年新药的进入:来自多利益相关者平台的提案 - 加速
Dept Oncol Children &
Adolescents Gustave Roussy Canc Campus Villejuif France;
Royal Marsden Hosp Oak Ctr Children &
Young People Paediat &
Adolescent Drug Dev Team London;
Create Chloe &
UK Representat aPODD London England;
European Med Agcy Prod Dev Sci Support Dept London England;
Gritstone Oncol Inc Emeryville CA USA;
Imagine Margo Fourqueux France;
Novartis AG Basel Switzerland;
EUROSTATION Belgium Fed Agcy Med &
Hlth Prod Brussels Belgium;
Univ York Ctr English Language Teaching York N Yorkshire England;
F Hoffmann Roche Ltd Oncol PDOA Div Pharmaceut Basel Switzerland;
EUROSTATION Belgium Fed Agcy Med &
Hlth Prod Brussels Belgium;
Novartis AG Basel Switzerland;
Jeunes Solidarite Canc Paris France;
aPODD Fdn London England;
Masaryk Univ Sch Med Univ Hosp Brno Dept Pediat Oncol Brno Czech Republic;
European Med Agcy Prod Dev Sci Support Dept London England;
Pharma GmbH &
Co KG TA Oncol Boehringer Ingelheim Biberach Germany;
Pharma GmbH &
Co KG TA Oncol Boehringer Ingelheim Biberach Germany;
Pfizer Italia Regulatory Strategy Oncol Milan Italy;
Pfizer Italia Regulatory Strategy Oncol Milan Italy;
Dept Oncol Children &
Adolescents Gustave Roussy Canc Campus Villejuif France;
Ctr Leon Berard Lyon France;
Gustave Roussy Drug Dev Dept DITEP Villejuif France;
Royal Marsden Hosp Adult Drug Dev Unit London England;
Univ Childrens Hosp III Hufelandstr Clin Res Paediat Drug Dev Paediat Haematol Oncol Essen;
Dept Oncol Children &
Adolescents Gustave Roussy Canc Campus Villejuif France;
Gustave Roussy Dept Clin Res Villejuif France;
Royal Marsden Hosp Oak Ctr Children &
Young People Paediat &
Adolescent Drug Dev Team London;
机译:联合青少年 - 成人早期临床试验,改善患有癌症的青少年新药的进入:来自多利益相关者平台的提案 - 加速
机译:创建一个独特的,多利益相关方的儿科肿瘤学平台,以改善患有癌症的儿童和青少年的药物开发
机译:创建一个独特的,多利益相关方的儿科肿瘤学平台,以改善患有癌症的儿童和青少年的药物开发
机译:SP1049C的临床研究,一种基于聚合物的蒽环类药物可有效抵抗耐药性肿瘤。上消化道癌适应症的II期试验和关键性III期试验结果
机译:临床前癌症模型的临床预测价值:体外细胞系,人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
机译:青少年-成人早期临床联合试验旨在改善患有癌症的青少年新药的获取:来自多方利益相关者平台的建议-ACCELERATE
机译:创建一个独特的,多利益相关方的儿科肿瘤学平台,以改善患有癌症的儿童和青少年的药物开发